[1]
|
Heidenreich, P.A., Bozkurt, B., Aguilar, D., et al. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e895-e1032. https://doi.org/10.1161/CIR.0000000000001063
|
[2]
|
Savarese, G., Becher, P.M., Lund, L.H., et al. (2023) Global Burden of Heart Failure: A Comprehensive and Updated Review of Epidemiology. Cardiovascular Research, 118, 3272-3287. https://doi.org/10.1093/cvr/cvac013
|
[3]
|
王华, 刘宇佳, 杨杰孚. 心力衰竭流行病学[J]. 临床心血管病杂志, 2023, 39(4): 243-247.
|
[4]
|
Adamo, L., Rocha-Resende, C., Prabhu, S.D., et al. (2020) Reappraising the Role of Inflammation in Heart Failure. Nature Reviews Cardiology, 17, 269-285. https://doi.org/10.1038/s41569-019-0315-x
|
[5]
|
Haybar, H., Pezeshki, S.M.S. and Saki, N. (2019) Evaluation of Complete Blood Count Parameters in Cardiovascular Diseases: An Early Indicator of Prognosis? Experimental and Molecular Pathology, 110, Article ID: 104267. https://doi.org/10.1016/j.yexmp.2019.104267
|
[6]
|
Murphy, S.P., Kakkar, R., McCarthy, C.P., et al. (2020) Inflammation in Heart Failure: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 75, 1324-1340. https://doi.org/10.1016/j.jacc.2020.01.014
|
[7]
|
Mantovani, A., Cassatella, M.A., Costantini, C., et al. (2011) Neutrophils in the Activation and Regulation of Innate and Adaptive Immunity. Nature Reviews Immunology, 11, 519-531. https://doi.org/10.1038/nri3024
|
[8]
|
Joseph, A.M., Monticelli, L.A. and Sonnenberg, G.F. (2018) Metabolic Regulation of Innate and Adaptive Lymphocyte Effector Responses. Immunological Reviews, 286, 137-147. https://doi.org/10.1111/imr.12703
|
[9]
|
Ouyang, H., Xiao, B., Huang, Y., et al. (2023) Baseline and Early Changes in the Neutrophil-Lymphocyte Ratio (NLR) Predict Survival Outcomes in Advanced Colorectal Cancer Patients Treated with Immunotherapy. International Immunopharmacology, 123, Article ID: 110703. https://doi.org/10.1016/j.intimp.2023.110703
|
[10]
|
Guo, Y., Xiang, D., Wan, J., et al. (2022) Focus on the Dynamics of Neutrophil-to-Lymphocyte Ratio in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis and Systematic Review. Cancers, 14, Article 5297. https://doi.org/10.3390/cancers14215297
|
[11]
|
Qiao, S., Gao, W. and Guo, S. (2020) Neutrophil-Lymphocyte Ratio (NLR) for Predicting Clinical Outcomes in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus: A Propensity Score Matching Analysis. Therapeutics and Clinical Risk Management, 16, 437-443. https://doi.org/10.2147/TCRM.S244623
|
[12]
|
Zhan, L., Liu, Y., Cheng, Y., et al. (2021) Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19. International Journal of General Medicine, 14, 3899-3907. https://doi.org/10.2147/IJGM.S317380
|
[13]
|
Bai, B., Cheng, M., Jiang, L., et al. (2021) High Neutrophil to Lymphocyte Ratio and Its Gene Signatures Correlate with Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction. Frontiers in Cardiovascular Medicine, 8, Article 614757. https://doi.org/10.3389/fcvm.2021.614757
|
[14]
|
Liu, T., Wang, B., Xiao, S., et al. (2023) Correlation Analysis between the Static and the Changed Neutrophil-to-Lymphocyte Ratio and In-Hospital Mortality in Critical Patients with Acute Heart Failure. Postgraduate Medicine, 135, 50-57. https://doi.org/10.1080/00325481.2022.2129177
|
[15]
|
Tamaki, S., Nagai, Y., Shutta, R., et al. (2023) Combination of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients with Acute Decompensated Heart Failure with Preserved Left Ventricular Ejection Fraction: A Multicenter Study. Journal of the American Heart Association, 12, e026326. https://doi.org/10.1161/JAHA.122.026326
|
[16]
|
Zhu, X., Cheang, I., Xu, F., et al. (2022) Long-Term Prognostic Value of Inflammatory Biomarkers for Patients with Acute Heart Failure: Construction of an Inflammatory Prognostic Scoring System. Frontiers in Immunology, 13, Article 1005697. https://doi.org/10.3389/fimmu.2022.1005697
|
[17]
|
García-Escobar, A., Vera-Vera, S., Tébar-Márquez, D., et al. (2023) Neutrophil-To-Lymphocyte Ratio an Inflammatory Biomarker, and Prognostic Marker in Heart Failure, Cardiovascular Disease and Chronic Inflammatory Diseases: New Insights for a Potential Predictor of Anti-Cytokine Therapy Responsiveness. Microvascular Research, 150, Article ID: 104598. https://doi.org/10.1016/j.mvr.2023.104598
|
[18]
|
Gawiński, C., Michalski, W., Mróz, A., et al. (2022) Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in Left-Sided Colorectal Cancer Patients. Biology, 11, Article 385. https://doi.org/10.3390/biology11030385
|
[19]
|
Lin, Z.Q., Ma, C., Cao, W.Z., et al. (2022) Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangiocarcinoma. Frontiers in Oncology, 12, Article 908907. https://doi.org/10.3389/fonc.2022.908907
|
[20]
|
Chen, S., Zhang, J., Qian, C., et al. (2023) Prognostic Value of Combined LMR and CEA Dynamic Monitoring in Postoperative Colorectal Cancer Patients. Journal of Inflammation Research, 16, 4229-4250. https://doi.org/10.2147/JIR.S422500
|
[21]
|
Liu, Z., Xv, Y., Liu, X. and Zhou, X.L. (2022) Associations of Systemic Inflammatory Markers with the Risks of Chronic Heart Failure: A Case-Control Study. Clinics, 77, Article ID: 100056. https://doi.org/10.1016/j.clinsp.2022.100056
|
[22]
|
Wang, R., Wu, J., Ye, H., et al. (2022) Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF). Medicina, 58, Article 1473. https://doi.org/10.3390/medicina58101473
|
[23]
|
Feldman, C. and Anderson, R. (2020) Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients with Community-Acquired Pneumonia. Frontiers in Immunology, 11, Article 577303. https://doi.org/10.3389/fimmu.2020.577303
|
[24]
|
Saad, H., Soliman, H.A., Mahmoud, B., et al. (2023) the Pathogenic Role of Oxidative Stress, Cytokine Expression, and Impaired Hematological Indices in Diabetic Cardiovascular Diseases. Inflammation, 46, 146-160. https://doi.org/10.1007/s10753-022-01718-w
|
[25]
|
Liu, D., Czigany, Z., Heij, L.R., et al. (2022) The Value of Platelet-to-Lymphocyte Ratio as a Prognostic Marker in Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Cancers, 14, Article 438. https://doi.org/10.3390/cancers14020438
|
[26]
|
Zhou, K., Cao, J., Lin, H., et al. (2022) Prognostic Role of the Platelet to Lymphocyte Ratio (PLR) in the Clinical Outcomes of Patients with Advanced Lung Cancer Receiving Immunotherapy: A Systematic Review and Meta-Analysis. Frontiers in Oncology, 12, Article 962173. https://doi.org/10.3389/fonc.2022.962173
|
[27]
|
Zhai, G., Wang, J., Liu, Y., et al. (2021) Platelet-Lymphocyte Ratio as a New Predictor of In-Hospital Mortality in Cardiac Intensive Care Unit Patients. Scientific Reports, 11, Article No. 23578. https://doi.org/10.1038/s41598-021-02686-1
|
[28]
|
Intan, R.E., Alkaff, F.F., Oktaviono, Y.H., et al. (2022) Retrospective Study of the Association between Platelet-to-Lymphocyte Ratio in Patients with Acute Coronary Syndrome on Admission to a Rural Referral Center in East Java, Indonesia, and the Incidence of New Symptomatic Heart Failure at 6 Months. Medical Science Monitor, 28, e935002. https://doi.org/10.12659/MSM.935002
|
[29]
|
Powrózek, T., Skwarek-Dziekanowska, A., Sobieszek, G., et al. (2024) Correlation between Neutrophil-to-Lymphocyte Ratio, Platelets-to-Lymphocyte Ratio, C-Reactive Protein-to-Albumin Ratio and Clinical Picture of Elderly Chronic Heart Failure Patients. Journal of Clinical Medicine, 13, Article 433. https://doi.org/10.3390/jcm13020433
|
[30]
|
Liu, Z., Zhang, R., Xv, Y., et al. (2022) A Novel Nomogram Integrated with Systemic Inflammation Markers and Traditional Prognostic Factors for Adverse Events’ Prediction in Patients with Chronic Heart Failure in the Southwest of China. Journal of Inflammation Research, 15, 6785-6800. https://doi.org/10.2147/JIR.S366903
|
[31]
|
Meng, L., Yang, Y., Hu, X., et al. (2023) Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis. Journal of Translational Medicine, 21, Article No. 79. https://doi.org/10.1186/s12967-023-03924-y
|
[32]
|
Huang, T., Peng, Q., Zhang, Y., et al. (2024) The Systemic Immune-Inflammation Index (SII) and Coronary Artery Lesions in Kawasaki Disease. Clinical and Experimental Medicine, 24, Article No. 4. https://doi.org/10.1007/s10238-023-01265-0
|
[33]
|
Wang, H., Nie, H., Bu, G., et al. (2023) Systemic Immune-Inflammation Index (SII) and the Risk of All-Cause, Cardiovascular, and Cardio-Cerebrovascular Mortality in the General Population. European Journal of Medical Research, 28, Article No. 575. https://doi.org/10.1186/s40001-023-01529-1
|
[34]
|
Yang, Y.L., Wu, C.H., Hsu, P.F., et al. (2020) Systemic Immune-Inflammation Index (SII) Predicted Clinical Outcome in Patients with Coronary Artery Disease. European Journal of Clinical Investigation, 50, e13230. https://doi.org/10.1111/eci.13230
|
[35]
|
Wang, Z., Qin, Z., Yuan, R., et al. (2023) Systemic Immune-Inflammation Index as a Prognostic Marker for Advanced Chronic Heart Failure with Renal Dysfunction. ESC Heart Failure, 10, 478-491. https://doi.org/10.1002/ehf2.14217
|
[36]
|
Zheng, H., Yin, Z., Luo, X., et al. (2024) Associations between Systemic Immunity-Inflammation Index and Heart Failure: Evidence from the NHANES 1999-2018. International Journal of Cardiology, 395, Article ID: 131400. https://doi.org/10.1016/j.ijcard.2023.131400
|